Article
Prevention of rejection of allogeneic endothelial cells in a biohybrid lung by silencing HLA-class I expression.
Biomaterials - 1 Sept 2014
Wiegmann Bettina, Figueiredo Constança, Gras Christiane, Pflaum Michael, Schmeckebier Sabrina, Korossis Sotirios, Haverich Axel, Blasczyk Rainer
Abstract excerpt
Variability in Human Leukocyte Antigens (HLA) remains a hurdle to the application of allogeneic cellular products. Due to insufficient autologous endothelial cell harvesting for the biohybrid lung, allogeneic human cord blood derived endothelial cells (HCBEC) were used for the endothelialization of poly-4-methyl-1-pentene (PMP) gas exchange membranes. Therefore, HLA class I expression was silenced stably in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
